IL-10 secretion increases signal persistence of HEMA-MMA-microencapsulated luciferase-modified CHO fibroblasts in mice

Tissue Engineering - Part A

Volumn 15, Issue 1, 2009, Pages 127-136

  Surzyn, Martin ^a   Symes, Juliane ^b   Medin, Jeffrey A ^b,c   Sefton, Michael V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLUMINESCENCE; CELL CULTURE; CELL MEMBRANES; DIGITAL IMAGE STORAGE; ENCAPSULATION; ESTERS; FUNCTIONAL POLYMERS; IMAGING SYSTEMS; MODULATION; OPTOELECTRONIC DEVICES;

CELL FUNCTIONS; CHINESE HAMSTERS; CHO CELLS; CONCEPT STUDIES; DURATION EFFECTS; HYDROXYETHYL METHACRYLATES; IMMUNE RESPONSES; IMMUNOMODULATORY AGENTS; IN VITRO; IN-VIVO; LUCIFERASE EXPRESSIONS; METHYL METHACRYLATES; NONDESTRUCTIVE IMAGING; POLYMER MEMBRANES; SHORT TIMES; SIGNAL EMITTED; SITE ENVIRONMENTS; TRACK CHANGES; TRANSFECTED CELLS; TRANSPLANTED CELLS; XENOGENEIC CELLS;

ENZYME ACTIVITY;

CRICETULUS GRISEUS; MURINAE; MUS;

EID: 58149265302     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0028     Document Type: Article

References (35)

1. Loudovaris, T., Mandel, T.E., and Charlton, B. CD4+T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+T cells and B cells. Transplantation 61, 1678, 1996.
2. Uludag, H., Horvath, V., Black, J.P., and Sefton,M.V. Viability and protein secretion from human hepatoma (HepG2) cells encapsulates in 400 μm polyacrylate microcapsules by submerged nozzle-liquid jet extrusion. Biotech Bioeng 44, 1199, 1994.
3. Tsang, E. Effects of the inflammatory response to HEMA: MMA microencapsulated cell survival: studies in immunocompromised mice [M.A.Sc. thesis]. Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, 2001.
4. Jones, K.S., Sefton, M.V., and Gorczynski, R.M. In vivo recognition by the host adaptive immune system of microencapsulated xenogeneic cells. Transplantation 78, 1454, 2004.
5. Vallbacka, J.J., and Sefton, M.V. Vascularization and improved in vivo survival of VEGF-secreting cells microencapsulated in HEMA-MMA. Tissue Eng 13, 2259, 2007.
6. Cheng, D., Lo, C., and Sefton,M.V. Effect ofmouse VEGF164 on the viability of HEMA-MMA microencapsulated cells in vivo: bioluminescence imaging. J Biomed Mater Res A (in press).
7. Ding, Y., Qin, L., Kotenko, S.V., Pestka, S., and Bromberg, J.S. A single amino acid determines the immunostimulatory activity of interleukin 10. J Exp Med 191, 213, 2000.
8. Janeway, C.A., Travers, P., Walport, M., and Schlomchik, M. Immunobiology, 5th edition. New York: Garland Publishing, 2001.
9. Bessis, N., Chiocchia, G., Kollias, G., Minty, A., Fournier, C., Fradelizi, D., and Boissier, M.C. Modulation of proinflammatory cytokine production in tumour necrosis factoralpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13. Clin Exp Immunol 111, 391, 1998.
10. Ormiston, M. The effect of VEGF-induced angiogenesis on the viability of microencapsulated cells in vivo [M.A.Sc. thesis]. Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, 2005.
11. Bowie, L.J., Irwin, R., Loken, M., de Luca, M., and Brand, L. Excited-state proton transfer and the mechanism of action of firefly luciferase. Biochemistry 12, 1852, 1973.
12. Yoshimitsu, M., Sato, T., Tao, K., Walia, J.S., Rasaiah, V.I., Sleep, G.T., Murray, G.J., Poeppl, A.G., Underwood, J., West, L., Brady, R.O., and Medin, J.A. Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. Proc Natl Acad Sci USA 101, 16909, 2004.
13. Lahooti, S., and Sefton, M.V. Microencapsulation of normal and transfected L929 fibroblasts in a HEMA-MMA copolymer. Tissue Eng 6, 139, 2000.
14. Massoud, T.F., and Gambhir, S.S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17, 545, 2003.
15. Greer, L.F., and Szalay, A.A. Imaging of light emission from the expression of luciferases in living cells and organisms: a review. Luminescence 17, 43, 2002.
16. Welsh, D.K., and Kay, S.A. Bioluminescence imaging in living organisms. Curr Opin Biotechnol 16, 73, 2005.
17. Schenborn, E., and Groskreutz, D. Reporter gene vectors and assays. Mol Biotechnol 13, 29, 1999.
18. Blum, J.S., Temenoff, J.S., Park, H., Jansen, J.A., Mikos, A.G., and Barry, M.A. Development and characterization of enhanced green fluorescent protein and luciferase expressing cell line for non-destructive evaluation of tissue engineering constructs. Biomaterials 25, 5809, 2004.
19. Lahooti, S., and Sefton, M.V. Agarose enhances the viability of intraperitoneally implanted microencapsulated L929 fibroblasts. Cell Transplant 9, 785, 2000.
20. Lee, K.H., Byun, S.S., Paik, J.Y., Lee, S.Y., Song, S.H., Choe, Y.S., and Kim, B.T. Cell uptake and tissue distribution of radioiodine labelled D-luciferin: implications for luciferase based gene imaging. Nucl Med Commun 24, 1003, 2003.
21. Meilander-Lin, N.J., Cheung, P.J., Wilson, D.L., and Bellamkonda, R.V. Sustained in vivo gene delivery from agarose hydrogel prolongs nonviral gene expression in skin. Tissue Eng 11, 546, 2005.
22. Dong, Z., Neiva, K.G., Jin, T., Zhang, Z., Hall, D.E., Mooney, D.J., Polverini, P.J., and Nor, J.E. Quantification of human angiogenesis in immunodeficient mice using a photon counting-based method. Biotechniques 43, 73, 2007.
23. Ho, T.Y., Chen, Y.S., and Hsiang, C.Y. Noninvasive nuclear factor-kappaB bioluminescence imaging for the assessment of host-biomaterial interaction in transgenic mice. Biomaterials 28, 4370, 2007.
24. Chen, X., Zhang, X., Larson, C., Chen, F., Kissler, H., and Kaufman, D.B. The epididymal fat pad as a transplant site for minimal islet mass. Transplantation 84, 122, 2007.
25. Sefton, M.V., Babensee, J.E., and Woodhouse, K.A. Innate and adaptive immune responses to tissue engineering. Semin Immunol 20, 83, 2008.
26. de Waal, M.R., Abrams, J., Bennett, B., Figdor, C.G., and de Vries, J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174, 1209, 1991.
27. Fiorentino, D.F., Bond, M.W., and Mosmann, T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170, 2081, 1989.
28. Qin, L., Chavin, K.D., Ding, Y., Tahara, H., Favaro, J.P., Woodward, J.E., Suzuki, T., Robbins, P.D., Lotze, M.T., and Bromberg, J.S. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol 156, 2316, 1996.
29. Shinozaki, K., Yahata, H., Tanji, H., Sakaguchi, T., Ito, H., and Dohi, K. Allograft transduction of IL-10 prolongs survival following orthotopic liver transplantation. Gene Ther 6, 816, 1999.
30. Moore, K.W., de Waal, M.R., Coffman, R.L, and O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19, 683, 2001.
31. Fiorentino, D.F., Zlotnik, A., Vieira, P., Mosmann, T.R., Howard, M., Moore, K.W., and O'Garra, A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146, 3444, 1991.
32. Zheng, X.X., Steele, A.W., Nickerson, P.W., Steurer, W., Steiger, J., and Strom, T.B. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J Immunol 154, 5590, 1995.
33. Furukawa, Y., Becker, G., Stinn, J.L., Shimizu, K., Libby, P., and Mitchell, R.N. Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol 155, 1929, 1999.
34. Wissing, K.M., Morelon, E., Legendre, C., de Pauw, L., Le-Beaut, A., Grint, P., Maniscalki, M., Ickx, B., Vereerstraeten, P., Chatenoud, L., Kreis, H., Goldman, M., and Abramowicz, D. A pilot trial of recombinant human interleukin-10 in kidney transplant recipients receiving OKT3 induction therapy. Transplantation 64, 999, 1997.
35. Sung, Y.H., and Lee, G.M. Enhanced human thrombopoietin production by sodium butyrate addition to serum-free suspension culture of bcl-2-overexpressing CHO cells. Biotechnol Prog 21, 50, 2005.